CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Pharmathene, Inc  (PIP)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Pharmathene Inc's Quick Ratio

PIP's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

PIP Quick Ratio (Mar 31 2017)
I. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Current Liabilities Change 2.53 % 56.61 % -2.01 % -41.81 % -15.59 %
Y / Y Cash & cash equivalent Change 1.37 % 681.79 % 25.78 % -9.47 % -16.49 %
Quick Ratio MRQ 7.06 36.46 7.08 5.39 7.14
Overall Ranking # 387 # # 82 # 423 # 559
Seq. Current Liabilities Change -40.07 % 14.07 % 23.81 % 21.14 % -8.46 %
Seq. Cash & cash equivalent Change -88.39 % 487.05 % 62.68 % -8.57 % -10.46 %



Quick Ratio first quarter 2017 Comment
Despite sequential decrease in Current Liabilities, Quick Ratio detoriated to 7.06 below company average Quick Ratio.

Within Major Pharmaceutical Preparations industry 88 other companies have achieved higher Quick Ratio than Pharmathene Inc in first quarter 2017. While Quick Ratio total ranking has deteriorated compare to previous quarter from to 387.

Explain Quick Ratio?
What are PIP Segments?
See Quick Ratio PIP on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 89
Sector # 157
S&P 500 # 387


Quick Ratio Statistics
High Average Low
36.46 7.37 2.46
(Sep 30 2016)   (Dec 31 2012)


You need to upgrade your Flash Player


Financial Statements
Pharmathene Inc's Current Liabilities $ 2 Millions Visit PIP's Balance sheet
Pharmathene Inc's Cash & cash equivalent $ 16 Millions Visit PIP's Balance sheet
Source of PIP's Sales Visit PIP's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Enanta Pharmaceuticals Inc  19.18 $ 175.573  Millions$ 9.154  Millions
Catalyst Pharmaceuticals, Inc.  19.17 $ 36.527  Millions$ 1.906  Millions
Chimerix Inc  18.73 $ 161.695  Millions$ 8.632  Millions
Biospecifics Technologies Corp  18.39 $ 47.872  Millions$ 2.603  Millions
Otonomy, Inc.  17.90 $ 168.124  Millions$ 9.390  Millions
Global Blood Therapeutics, Inc.  16.57 $ 244.324  Millions$ 14.747  Millions
Scynexis Inc  16.35 $ 54.899  Millions$ 3.358  Millions
Xenon Pharmaceuticals Inc.  16.16 $ 58.027  Millions$ 3.591  Millions
Kura Oncology, Inc.  16.04 $ 59.153  Millions$ 3.688  Millions
Aduro Biotech, Inc.  14.76 $ 353.961  Millions$ 23.975  Millions
Aeglea Biotherapeutics, Inc.  14.62 $ 57.868  Millions$ 3.957  Millions
Nivalis Therapeutics, Inc.  13.90 $ 52.674  Millions$ 3.789  Millions
Zafgen, Inc.  13.60 $ 116.936  Millions$ 8.597  Millions
Adamas Pharmaceuticals Inc  13.57 $ 112.073  Millions$ 8.261  Millions
Vital Therapies Inc  13.43 $ 86.636  Millions$ 6.450  Millions
Aldeyra Therapeutics, Inc.  12.96 $ 31.213  Millions$ 2.409  Millions
Kempharm, Inc  12.94 $ 62.223  Millions$ 4.808  Millions
Evoke Pharma Inc  12.90 $ 14.655  Millions$ 1.136  Millions
Beigene, Ltd.  12.83 $ 327.476  Millions$ 25.522  Millions
Nexvet Biopharma Plc  12.67 $ 14.521  Millions$ 1.146  Millions
Tonix Pharmaceuticals Holding Corp.  12.60 $ 22.434  Millions$ 1.780  Millions
Clovis Oncology, Inc.  12.39 $ 408.827  Millions$ 33.001  Millions
Neurotrope, Inc.  12.21 $ 23.765  Millions$ 1.947  Millions
Esperion Therapeutics, Inc.  11.94 $ 181.884  Millions$ 15.234  Millions
Lipocine Inc.  11.43 $ 26.797  Millions$ 2.345  Millions
Mei Pharma, Inc.  11.38 $ 56.760  Millions$ 4.989  Millions
Zynerba Pharmaceuticals, Inc.  11.16 $ 77.493  Millions$ 6.941  Millions
Bellicum Pharmaceuticals, Inc.  10.94 $ 147.564  Millions$ 13.483  Millions
Rexahn Pharmaceuticals, Inc.  10.80 $ 18.534  Millions$ 1.715  Millions
Clearside Biomedical, Inc.  10.78 $ 77.451  Millions$ 7.186  Millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com